These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 35675604

  • 21. Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.
    Muhammad J, Yusof Y, Ahmad I, Norhayati MN.
    BMC Womens Health; 2022 Jan 15; 22(1):14. PubMed ID: 35033041
    [Abstract] [Full Text] [Related]

  • 22. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
    Kitade M, Kumakiri J, Kobori H, Murakami K.
    Trials; 2024 May 24; 25(1):343. PubMed ID: 38790029
    [Abstract] [Full Text] [Related]

  • 23. Impact of relugolix combination therapy on functioning and quality of life in women with endometriosis-associated pain.
    As-Sanie S, Abrao MS, Reznichenko G, Wilk K, Zhong Y, Perry J, Hunsche E, Soulban G, Becker CM.
    Fertil Steril; 2024 Oct 24; 122(4):687-695. PubMed ID: 38906210
    [Abstract] [Full Text] [Related]

  • 24. Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial.
    Brown E, Kroll R, Li H, Ng J, Pinsky B, Rodriguez JW, Thomas J, Snabes MC.
    Obstet Gynecol; 2023 Nov 01; 142(5):1068-1076. PubMed ID: 37769311
    [Abstract] [Full Text] [Related]

  • 25. Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain.
    Blair HA.
    Drugs; 2024 Apr 01; 84(4):449-457. PubMed ID: 38592603
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary.
    Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A.
    J Comp Eff Res; 2024 Aug 01; 13(8):e230194. PubMed ID: 38934918
    [Abstract] [Full Text] [Related]

  • 29. Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.
    Osuga Y, Seki Y, Tanimoto M, Kusumoto T, Kudou K, Terakawa N.
    BMC Womens Health; 2021 Jun 21; 21(1):250. PubMed ID: 34154590
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A Plain Language Summary to learn about relugolix combination therapy for the treatment of pain associated with endometriosis.
    Giudice LC, As-Sanie S, Arjona Ferreira JC, Becker CM, Abrao MS, Lessey BA, Dynowski K, Wilk K, Li Y, Mathur V, Wagman RB, Johnson NP.
    Pain Manag; 2023 Nov 21; 13(11):631-640. PubMed ID: 37982388
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH, Lumsden MA, Fauser BC, Terrill P, Bestel E.
    Hum Reprod; 2014 Mar 21; 29(3):480-9. PubMed ID: 24457604
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.